Thalidomide for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

Conclusion Addition of thalidomide was generally well tolerated and improved prevention of CINV in patients receiving cisplatin-based chemotherapy to some degree, especially for delayed nausea.
Source: Australasian Medical Journal - AMJ - Category: Journals (General) Source Type: research